Metap Inc.: Metaverse Project GensoKishi Online Announces a Closed Alpha Ticket (Bronze) Lottery
GensoKishi Online -Meta World- is developed under the license of the well-known Japanese 3D MMO title “Elemental Knights Online.” The iconic game has a 14 year history and has accumulated a total of 8 million downloads worldwide. It already has a 3D MMORPG game with active users, with a fully-functioning 3D metaverse, that simultaneously connects users from around the world, be it smartphones, PCs, or video game consoles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005812/en/
GensoKishi Closed Alpha test (Graphic: Business Wire)
The game recently announced its collaboration with gaming legend Yoshitaka Amano to design their NFT collection.
Since the release of the GensoKishi website and various social media channels on December 2, 2021, GensoKishi have achieved a number of records to date. The governance token of the GensoKishi is currently more than 50 times higher than the initial listing price of Bybit, the first exchange to list MV token.
GensoKishi Online have opened up applications to enter the lottery for the Closed Alpha Bronze Tickets. Winners of the lottery will be provided exclusive access to GensoKishi’s Closed Alpha Test.
Click here to read details about Closed Alpha Test
Click here to visit the GensoKishi Online Metaworld Official Website
Campaign details regarding the Closed Alpha Testing Period
All participants of the Closed Alpha will receive a limited edition NFT to commemorate their participation in the Testing Period.
During the Closed Alpha Testing Period, an item called the "Alpha Hunter's Certificate" will drop at a certain probability rate when players defeat monsters during gameplay.
Each "Alpha Hunter's Certificate" will be treated as 1 point, and at the end of the first half and the second half of the Closed Alpha Testing Period, a ranking will be generated based on the number of “Alpha Hunter's Certificate” collected. The top 10 players of this rank will receive a limited edition NFT (equivalent to SR), and the top 11 to 100 players will receive a limited edition NFT (equivalent to SR).
How do you apply for the Closed Alpha Bronze Ticket lottery?
Please complete the tasks listed in here and submit your application via the application form.
Application Period for the Closed Alpha Bronze Ticket
- Start Date: May 3, 2022 12:00 (GMT+8)
- End Date: May 17, 2022 23:59 (GMT+8)
- Scheduled date of ticket distribution to winners: May 27, 2022
*Please note that applications cannot be accepted after the end date of the application period.
*Please note that the ticket distribution date is subject to change.
Closed Alpha Period
The specific schedule will be announced at a later date.
Apply now from here
*Check out the GensoKishi White Paper:
https://genso.game/pdf/WhitePaper_genso_EN.pdf
GensoKishi Online -META WORLD- Community
Official Site : https://genso.game/
Twitter: https://twitter.com/genso_meta
Discord: https://discord.gg/gensometa
Telegram: https://t.me/gensometamain
YouTube: https://www.youtube.com/channel/UCMi4wGMEWgC9VVps8d_NLDA
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005812/en/
Contact information
Metap Inc.
Maxi Kuan
Phone number: +886935312638
E-mail address: info@genso.game
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom